Market Place
Sourcing Support
Lykos still plotting path to approval for rejected MDMA therapy
18 Jan 2025 //
FIERCE BIOTECH
Lykos Loses Five Board Directors After FDA Rejection
16 Jan 2025 //
BIOSPACE
Lykos accepts FDA’s view that reviving rejected MDMA therapy
22 Oct 2024 //
FIERCE BIOTECH
MDMA Drug Developers Reprioritize After Lykos PTSD Rejection
30 Sep 2024 //
BIOSPACE
Lykos` longtime CEO to step down in latest shakeup after MDMA drug setback
06 Sep 2024 //
REUTERS
Lykos CEO to depart after FDA rejection, layoffs
06 Sep 2024 //
REUTERS
Lykos Therapeutics Appoints Michael Mullette as Interim CEO, Dr. David as CMO
05 Sep 2024 //
PR NEWSWIRE
PharmAla Launches Tool For MDMA Research Amid Psychedelics Snag
28 Aug 2024 //
FIERCE BIOTECH
Lykos` woes mount as FDA expands probe into its MDMA-based research
27 Aug 2024 //
FIERCE BIOTECH
US FDA widens probe of MDMA-based drug studies, WSJ reports
24 Aug 2024 //
REUTERS
Lykos to lay off 100 employees after MDMA drug setback; founder to exit board
16 Aug 2024 //
REUTERS
Lykos Therapeutics Reorganizes After FDA Decision On PTSD Treatment
15 Aug 2024 //
PR NEWSWIRE
In a one-two punch for Lykos, 3 articles on MDMA treatment retracted
12 Aug 2024 //
FIERCE BIOTECH
Three MDMA Treatment Articles Retracted Due To Unethical Conduct
12 Aug 2024 //
FIERCE BIOTECH
MAPS Responds To FDA Complete Response Letter For MDMA-Assisted Therapy
10 Aug 2024 //
GLOBENEWSWIRE
PharmAla Comments On FDA MDMA Decision, Announces ALA-002 Patent Grant
09 Aug 2024 //
GLOBENEWSWIRE
Lykos takes another hit as ICER lays out for MDMA-based treatment
27 Jun 2024 //
ENDPOINTS
With MDMA debate spreading, Lykos CEO tries to dispel concerns
13 Jun 2024 //
FIERCE BIOTECH
After ‘sobering’ FDA panel, psychedelics supporters wonder what’s next
07 Jun 2024 //
BIOPHARMADIVE
US FDA panel votes against first MDMA-based PTSD treatment
05 Jun 2024 //
REUTERS
Lykos: Updates On FDA Panel For MDMA-Assisted PTSD Therapy
04 Jun 2024 //
PR NEWSWIRE
Ahead Of MDMA Approval, FDA Raises Trial Design, Safety Concerns
01 Jun 2024 //
ENDPTS
As adcomm looms, ICER raises questions over Lykos’ MDMA studies
15 May 2024 //
ENDPTS
FDA advisers to weigh first psychedelic therapy in early June
07 May 2024 //
FIERCE BIOTECH
US FDA panel to discuss first psychedelic-assisted PTSD treatment next month
07 May 2024 //
REUTERS
Psychedelic-assisted drug developer MAPS PBC nabs $100M
05 Jan 2024 //
ENDPTS
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.